{"cik":875320,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"VERTEX PHARMACEUTICALS INC / MA","units":{"USD":[{"end":"2011-03-31","val":105000000,"accn":"0001047469-11-004721","fy":2011,"fp":"Q1","form":"10-Q","filed":"2011-05-06","frame":"CY2011Q1I"},{"end":"2011-06-30","val":105000000,"accn":"0001047469-11-007153","fy":2011,"fp":"Q2","form":"10-Q","filed":"2011-08-09","frame":"CY2011Q2I"},{"end":"2011-09-30","val":105000000,"accn":"0001047469-11-009007","fy":2011,"fp":"Q3","form":"10-Q","filed":"2011-11-03","frame":"CY2011Q3I"}]}}